Skip to main content
SpringerLink
Log in

The Most Common Indications

  • Chapter
Botulinum Toxin in Aesthetic Medicine

Abstract

The following chapters describe the most common indications. Although written by both authors separately, the chapters follow the same sequence and try to depict the procedures in the most ‘hands on’ way possible.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

5.3.8 References

  • Ahn MS et al. (2000) Temporal brow lift using botulinum toxin A. Plast Reconstr Surg 105(3):1129-35; discussion pp 1136-9

    Google Scholar 

  • Balikian RV, Zimbler MS (2005) Primary and adjunctive uses of botulinum toxin type A in the periorbital region. Facial Plast Surg Clin North Am 13(4):583-90

    Article  PubMed  Google Scholar 

  • Bulstrode NW, Grobbelaar AO (2002) Long-term prospective follow-up of botulinum toxin treatment for facial rhytides. Aesthetic Plast Surg 26(5):356-9

    Article  PubMed  CAS  Google Scholar 

  • Chen AH, Frankel AS (2003) Altering brow contour with botulinum toxin. Facial Plast Surg Clin North Am 11(4):457-64

    Article  PubMed  Google Scholar 

  • Cook BE Jr et al. (2001) Depressor supercilii muscle: anatomy, histology, and cosmetic implications. Ophthal Plast Reconstr Surg 17(6):404-11

    Article  PubMed  Google Scholar 

  • de Almeida AR, Cernea SS (2001) Regarding browlift with botulinum toxin. Dermatol Surg 27(9):848

    Article  PubMed  Google Scholar 

  • Frankel AS, Kamer FM (1998) Chemical browlift. Arch Otolaryngol Head Neck Surg 124(3):321-3

    PubMed  CAS  Google Scholar 

  • Huilgol SC et al. (1999) Raising eyebrows with botulinum toxin. Dermatol Surg 25(5):373-5; discussion p 376

    Article  Google Scholar 

  • Klein AW (2004) Botox for the eyes and eyebrows. Dermatol Clin 22(2):145-9

    Article  PubMed  CAS  Google Scholar 

  • Koch RJ et al. (1997) Contemporary management of the aging brow and forehead. Laryngoscope 107(6):710-5

    Article  PubMed  CAS  Google Scholar 

  • Kokoska MS et al. (2002) Modifications of eyebrow position with botulinum exotoxin A. Arch Facial Plast Surg 4(4):244-7

    Article  PubMed  Google Scholar 

  • Kokoska MS et al. (2002) Modifications of eyebrow position with botulinum exotoxin A. Arch Facial Plast Surg 4(4):244-7

    Article  PubMed  Google Scholar 

  • Le Louarn C (1998) Botulinum toxin and facial wrinkles: a new injection procedure. Ann Chir Plast Esthet 43(5):526-33

    PubMed  Google Scholar 

  • Le Louarn C (2001) Botulinum toxin A and facial lines: the variable concentration. Aesthetic Plast Surg 25(2):73-84

    Article  PubMed  Google Scholar 

  • Le Louarn C (2004) Functional facial analysis after botulin on toxin injection. Ann Chir Plast Esthet 49(5):527-36

    Article  PubMed  Google Scholar 

  • Lee CJ et al. (2006) The results of periorbital rejuvenation with botulinum toxin A using two different protocols. Aesthetic Plast Surg 30(1):65-70

    Article  PubMed  Google Scholar 

  • Matarasso A, Hutchinson O (2003) Evaluating rejuvenation of the forehead and brow: an algorithm for selecting the appropriate technique. Plast Reconstr Surg 112(5):1467-9

    Article  PubMed  Google Scholar 

  • Michelow BJ, Guyuron B (1997) Rejuvenation of the upper face. A logical gamut of surgical options. Clin Plast Surg 24(2):199-212

    Google Scholar 

  • Muhlbauer W, Holm C (1998) Eyebrow asymmetry: ways of correction. Aesthetic Plast Surg 22(5):366-71

    Article  PubMed  CAS  Google Scholar 

  • Ozsoy Z et al. (2005) A new technique applying botulinum toxin in narrow and wide foreheads. Aesthetic Plast Surg 29(5):368-72

    Article  PubMed  Google Scholar 

  • Redaelli A, Forte R (2003) How to avoid brow ptosis after forehead treatment with botulinum toxin. J Cosmet Laser Ther 5(3-4):220-2

    Article  PubMed  CAS  Google Scholar 

  • Sadick NS (2004) The cosmetic use of botulinum toxin type B in the upper face. Clin Dermatol 22(1):29-33

    Article  PubMed  Google Scholar 

5.4.9 References

  • Batniji RK, Falk AN (2004) Update on botulinum toxin use in facial plastic and head and neck surgery. Curr Opin Otolaryngol Head Neck Surg 12(4):317-22

    Article  PubMed  Google Scholar 

  • Baumann L et al. (2003) A double-blinded, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B)-purified neurotoxin complex for the treatment of crow’s feet: a double-blinded, placebo-controlled trial. Dermatol Surg 29(5):508-15

    Article  PubMed  Google Scholar 

  • Carruthers J et al. (2004) Consensus recommendations on the use of botulinum toxin type a in facial aesthetics. Plast Reconstr Surg 114(6 Suppl):1S-22S

    Article  PubMed  Google Scholar 

  • Fagien S (2000) Intraoperative injection of botulinum toxin A into orbicularis oculi muscle for the treatment of crow’s feet. Plast Reconstr Surg 105(6):2226-8

    Article  PubMed  Google Scholar 

  • Flynn TC et al. (2003) Botulinum A toxin (BOTOX) in the lower eyelid: dose-finding study. Dermatol Surg 29(9):943-50; discussion 950-1

    Article  PubMed  Google Scholar 

  • Guerrissi JO (2000) Intraoperative injection of botulinum toxin A into orbicularis oculi muscle for the treatment of crow’s feet. Plast Reconstr Surg 104(6):2219-25

    PubMed  Google Scholar 

  • Kane MA (2003) Classification of crow’s feet patterns among caucasian women: the key to individualizing treatment. Plast Reconstr Surg 112(5 Suppl):33S-39S

    Article  PubMed  Google Scholar 

  • Klein AW (2004) Botox for the eyes and eyebrows. Dermatol Clin 22(2):145-9

    Article  PubMed  CAS  Google Scholar 

  • Klein AW (2004) Contraindications and complications with the use of botulinum toxin. Clin Dermatol 22(1):66-75

    Article  PubMed  Google Scholar 

  • Guerrissi JO (2003) Intraoperative injection of botulinum toxin A into the orbicularis oculi muscle for the treatment of crow’s feet. Plast Reconstr Surg 112(5 Suppl):161S-3S

    Article  PubMed  Google Scholar 

  • Lee CJ et al. (2006) The results of periorbital rejuvenation with botulinum toxin A using two different protocols. Aesthetic Plast Surg 30(1):65-70

    Article  PubMed  Google Scholar 

  • Levy JL et al. (2004) Botulinum toxin A: a 9-month clinical and 3D in vivo profilometric crow’s feet wrinkle formation study. J Cosmet Laser Ther 6(1):16-20

    Article  PubMed  Google Scholar 

  • Lowe NJ et al. (2005) Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow’s feet. Dermatol Surg 31(3):257-62

    PubMed  CAS  Google Scholar 

  • Lowe NJ et al. (2002) Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow’s feet. J Am Acad Dermatol 47(6):834-40

    Article  PubMed  Google Scholar 

  • Matarasso SL, Matarasso A (2001) Treatment guidelines for botulinum toxin type A for the periocular region and a report on partial upper lip ptosis following injections to the lateral canthal rhytids. Plast Reconstr Surg 108(1):208-14; discussion pp 215-7

    Article  Google Scholar 

  • Naik MN et al. (2005) Botulinum toxin in ophthalmic plastic surgery. Indian J Ophthalmol 53(4):279-88

    Article  PubMed  Google Scholar 

  • Semchyshyn N, Sengelmann RD (2003) Botulinum toxin A treatment of perioral rhytides. Dermatol Surg 29(5):490-5; discussion p 495

    Article  Google Scholar 

  • Flynn TC et al. (2003) Botulinum A toxin (BOTOX) in the lower eyelid: dose-finding study. Dermatol Surg 29(9):943-50; discussion pp 950-1

    Article  Google Scholar 

  • Flynn TC et al. (2001) Botulinum-A toxin treatment of the lower eyelid improves infraorbital rhytides and widens the eye. Dermatol Surg 27(8):703-8

    Article  PubMed  CAS  Google Scholar 

  • Balikian RV, Zimbler MS (2005) Primary and adjunctive uses of botulinum toxin type A in the periorbital region. Facial Plast Surg Clin North Am 13(4):583-90

    Article  PubMed  Google Scholar 

  • Frankel AS (1999) Botox for rejuvenation of the periorbital region. Facial Plast Surg 15(3):255-62

    Article  PubMed  CAS  Google Scholar 

  • Kim DW et al. (2003) Botulinum toxin A for the treatment of lateral periorbital rhytids. Facial Plast Surg Clin North Am 11(4):445-51

    Article  PubMed  Google Scholar 

  • Lee CJ et al. (2006) The results of periorbital rejuvenation with botulinum toxin A using two different protocols. Aesthetic Plast Surg 30(1):65-70

    Article  PubMed  Google Scholar 

  • Spiegel JH (2005) Treatment of periorbital rhytids with botulinum toxin type A: maximizing safety and results. Arch Facial Plast Surg 7(3):198-202

    Article  PubMed  Google Scholar 

5.5.8 References

  • Ahn KY et al. (2000) Botulinum toxin A for the treatment of facial hyperkinetic wrinkle lines in Koreans. Plast Reconstr Surg 105(2):778-84

    Article  PubMed  CAS  Google Scholar 

  • Carruthers J, Carruthers A (2003) Aesthetic botulinum A toxin in the mid and lower face and neck. Dermatol Surg 29(5):468-76

    Article  PubMed  Google Scholar 

  • Carruthers J et al. (2004) Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg 114(6 Suppl):1S-22S

    Article  PubMed  Google Scholar 

  • Huang W et al. (2000) Browlift with botulinum toxin. Dermatol Surg 26(1):55-60

    Article  PubMed  CAS  Google Scholar 

5.6.9 References

  • Rees TD (1978) Rhinoplasty in the older patient. Ann Plast Surg 1:27

    PubMed  CAS  Google Scholar 

  • Patterson C (1980) The aging nose: characteristics and correction. Otolaryngol Clin North Am 13:275

    PubMed  CAS  Google Scholar 

  • Rohrich RJ et al. (2000) Importance of the depressor septi nasi muscle in rhinoplasty: anatomic study and clinical application. Plast Reconstr Surg 105:376

    Article  PubMed  CAS  Google Scholar 

  • Batniji RK, Falk AN (2004) Update on botulinum toxin use in facial plastic and head and neck surgery. Curr Opin Otolaryngol Head Neck Surg 12(4):317-22

    Article  PubMed  Google Scholar 

  • Carruthers J et al. (2004) Consensus recommendations on the use of botulinum toxin type a in facial aesthetics. Plast Reconstr Surg 114(6 Suppl):1S-22S

    Article  PubMed  Google Scholar 

  • Dayan SH, Kempiners JJ (2005) Treatment of the lower third of the nose and dynamic nasal tip ptosis with Botox. Plast Reconstr Surg 115(6):1784-5

    Article  PubMed  CAS  Google Scholar 

  • De Maio M (2004) The minimal approach: an innovation in facial cosmetic procedures. Aesthetic Plast Surg 28(5):295-300

    Article  PubMed  Google Scholar 

  • Kane MA (2003) The effect of botulinum toxin injections on the nasolabial fold. Plast Reconstr Surg 112(5 Suppl):66S-72S; discussion pp 73S-74S

    Google Scholar 

  • Le Louarn C (2001) Botulinum toxin A and facial lines: the variable concentration. Aesthetic Plast Surg 25(2):73-84

    Article  PubMed  Google Scholar 

  • Tamura BM et al. (2005) Treatment of nasal wrinkles with botulinum toxin. Dermatol Surg 31(3):271-5

    Article  PubMed  CAS  Google Scholar 

5.7.8 References

  • de Maio M (2004) The minimal approach: an innovation in facial cosmetic procedures. Aesthetic Plast Surg 28(5):295-300

    Article  PubMed  Google Scholar 

  • Kane MA (2003) The effect of botulinum toxin injections on the nasolabial fold. Plast Reconstr Surg 112(5 Suppl):66S-72S; discussion 73S-74S

    PubMed  Google Scholar 

  • Kane MA (2005) The functional anatomy of the lower face as it applies to rejuvenation via chemodenervation. Facial Plast Surg 21(1):55-64

    Article  PubMed  CAS  Google Scholar 

  • Klein AW (2004) Contraindications and complications with the use of botulinum toxin. Clin Dermatol 22(1):66-75

    Article  PubMed  Google Scholar 

  • McCracken MS et al. (2006) Hyaluronic acid gel (Restylane) filler for facial rhytids: lessons learned from American Society of Ophthalmic Plastic and Reconstructive Surgery member treatment of 286 patients. Ophthal Plast Reconstr Surg 22 (3):188-91

    Article  PubMed  Google Scholar 

5.8.8 References

  • Bikhazi NB, Maas CS (1997) Refinement in the rehabilitation of the paralyzed face using botulinum toxin. Otolaryngol Head Neck Surg 117(4):303-7

    Article  PubMed  CAS  Google Scholar 

  • De Maio M (2004) The minimal approach: an innovation in facial cosmetic procedures. Aesthetic Plast Surg 28(5):295-300

    Article  PubMed  Google Scholar 

  • Ellis DA, Tan AK (1997) Cosmetic upper-facial rejuvenation with botulinum. J Otolaryngol 26(2):92-6

    PubMed  CAS  Google Scholar 

  • Matarasso SL, Matarasso A (2001) Treatment guidelines for botulinum toxin type A for the periocular region and a report on partial upper lip ptosis following injections to the lateral canthal rhytids. Plast Reconstr Surg 108(1):208-14; discussion pp 215-7

    Article  Google Scholar 

  • Spiegel JH, DeRosa J (2005) The anatomical relationship between the orbicularis oculi muscle and the levator labii superioris and zygomaticus muscle complexes. Plast Reconstr Surg 116(7):1937-42; discussion pp 1943-4

    Article  CAS  Google Scholar 

5.9.8 References

  • Corliss R (2002) Smile--you’re on botox! Time 159(7):59

    PubMed  Google Scholar 

  • Tulley P et al. (2000) Paralysis of the marginal mandibular branch of the facial nerve: treatment options. Br J Plast Surg 53(5):378-85

    Article  PubMed  CAS  Google Scholar 

5.10.8 References

  • Salasche S, Bernstein G (1988) Senkarik M: Surgical anatomy of the skin. Appleton and Lange, East Norwalk, CT

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Dermatologie, CHARITÉ - UNIVERSITÄTSMEDIZIN BERLIN, Charitéplatz 1, 10117, Berlin, Deutschland

    Berthold Rzany

  2. Faculty of Medicine of the University of Sao Paulo, Av. Ibirapuera, 2907 - cj. 1202 Moema, 04029-200, Sao Paulo, Brazil

    Mauricio de Maio

Authors
  1. Mauricio de Maio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Berthold Rzany
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mauricio de Maio .

Editor information

Editors and Affiliations

  1. Faculty of Medicine of the University of Sao Paulo, Av. Ibirapuera, 2907 - cj. 1202, 04029-200, Sao Paulo, Brazil

    Mauricio de Maio

  2. Klinik für Dermatologie, CHARITÉ - UNIVERSITÄTSMEDIZIN BERLIN, Charitéplatz 1, 10117, Berlin, Deutschland

    Berthold Rzany

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

de Maio, M., Rzany, B. (2007). The Most Common Indications. In: de Maio, M., Rzany, B. (eds) Botulinum Toxin in Aesthetic Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-34095-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-34095-9_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-34094-2

  • Online ISBN: 978-3-540-34095-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation